A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema
Status:
Available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Establish the efficacy of initial high frequency loading of intravitreal pegaptanib bi-weekly
during the initial treatment period when the VEGF levels are the greatest and then gradually
extending the administration frequency to monthly as homeostasis ensues for the treatment of
DME, as measured by best-corrected visual acuity.